EP
TNDM icon

Essential Partners’s Tandem Diabetes Care TNDM Stock Holding History

Essential Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4K Sell
265
-2,623
-91% -$45.8K ﹤0.01% 1640
2026
Q1 		$55.4K Buy
2,888
+1
+0% +$22 0.02% 575
2025
Q4 		$63.5K Buy
2,887
+25
+0.9% +$451 0.02% 554
2025
Q3 		$34.7K Buy
+2,862
New +$38.7K 0.01% 717

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Essential Partners's TNDM Position: Q2 2026 in Review

Essential Partners reduced its Tandem Diabetes Care (TNDM) stake by 91% in Q2 2026, selling an estimated $45.8K and leaving 265 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Essential Partners first reported a position in TNDM in Q3 2025 and has held it in 4 quarters since. The position peaked at $63.5K in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Essential Partners held 265 shares of Tandem Diabetes Care worth $4K as of Q2 2026.
  • Essential Partners sold 2,623 Tandem Diabetes Care shares in Q2 2026, an estimated $45.8K.
  • Tandem Diabetes Care made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1640 holding.
  • Essential Partners first reported a position in Tandem Diabetes Care in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's Tandem Diabetes Care position peaked at $63.5K in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.